MSc Biotechnology

1 Year On Campus Masters Program

University College Cork UCC

Program Overview

The MSc Biotechnology at UCC is a one‑year full‑time program designed to equip graduates with both the theoretical knowledge and practical skills required for careers in biotechnology and biopharmaceutical industries. It suits science graduates who want to combine advanced laboratory training with industry‑led modules and a six‑month work placement, ensuring they graduate with both academic depth and real‑world experience.

Curriculum Structure

Year 1 — Semester 1 (Autumn)
Students begin with a strong foundation in molecular and cellular biology through BC6001 Cell and Molecular Biology. They also study PF6301 Biopharmaceuticals: Formulation, Secondary Processing and Regulation, gaining insight into drug formulation and regulatory frameworks. The semester introduces BC6016 Advanced Therapy Medicinal Products (ATMPs), including laboratory training in biosafety and aseptic techniques, alongside BT6007 Practitioner Based Skills in Biotechnology, which develops professional and technical competencies.

Year 1 — Semester 2 (Spring)
The second stage emphasizes advanced laboratory and analytical skills through BC6013 Laboratory-based Technical and Analytical Skills. Students explore cutting‑edge therapies in BC6015 Cell and Gene Therapy and BC6017 Cell Immunotherapy Manufacturing Science and Technology. The semester also includes PE6008 Bioprocess Engineering, where students learn principles of process validation, quality assurance, and bioprocess monitoring in GMP/GLP environments.

Year 1 — Semester 3 (Summer)
The program culminates in a six‑month industry work placement and dissertation (BT6005). Students conduct independent research projects in collaboration with leading biopharmaceutical companies, supervised jointly by UCC academics and industry mentors. This immersive placement connects academic theory with real‑world practice, offering hands‑on experience with technologies such as mammalian cell culture, recombinant DNA, CRISPR/Cas9, ELISA, SDS‑PAGE, and Western blotting.

Focus Areas

Cell and molecular biology, advanced therapy medicinal products (ATMPs), cell and gene therapy, immunotherapy manufacturing, bioprocess engineering, regulatory frameworks, laboratory analytics.

Learning Outcomes

Graduates will:

Master advanced laboratory techniques in biotechnology and biopharmaceuticals.
Apply knowledge of ATMPs, gene therapy, and immunotherapy to real industry contexts.
Understand bioprocess engineering, regulation, and GMP/GLP standards.
Conduct independent research and present findings in a professional dissertation.
Develop transferable skills in teamwork, leadership, project management, and communication.

Professional Alignment (Accreditation)

This NFQ Level 9 Master’s program is industry‑informed and continually updated to reflect advances in biologics, cell, and gene therapies. The six‑month placement ensures graduates are aligned with employer needs and recognized internationally for their skills.

Reputation (Employability Rankings)

UCC’s MSc Biotechnology is one of Ireland’s most established biotechnology master’s programs, with 90% of graduates employed in industry and 10% progressing to PhD study. UCC ranks among the top 2% of universities worldwide and is consistently recognized for its strong industry connections and graduate employability.

Experiential Learning (Research, Projects, Internships etc.)

One of the most powerful aspects of UCC’s MSc Biotechnology is how it immerses students in real laboratory practice and industry‑level training. You won’t just learn concepts — you’ll spend time in advanced facilities, master bioprocess engineering tools, and apply your skills during a six‑month industry placement. This combination of academic depth and professional exposure ensures you graduate with the confidence to step directly into the biopharma sector.

Here’s how experiential learning is built into the program:

Specialist Laboratories: Students train in UCC’s School of Biochemistry and Cell Biology labs, gaining hands‑on experience with mammalian cell culture, recombinant DNA technology, CRISPR/Cas9, ELISA, SDS‑PAGE, and Western blotting.
Industry Placement: A six‑month work placement (BT6005 Dissertation and Work Placement) is a core part of the program, giving students direct exposure to biopharmaceutical companies and supervised projects that bridge theory with practice.
Analytical & Technical Skills: Modules such as BC6013 Laboratory-based Technical and Analytical Skills and PE6008 Bioprocess Engineering train students in GMP/GLP standards, process validation, and bioprocess monitoring.
Advanced Therapy Training: Courses like BC6015 Cell and Gene Therapy and BC6017 Cell Immunotherapy Manufacturing Science and Technology provide practical insight into cutting‑edge therapies, including manufacturing science and regulatory compliance.
Group Projects: Collaborative assignments in BT6007 Practitioner Based Skills in Biotechnology and PF6301 Biopharmaceuticals: Formulation, Secondary Processing and Regulation simulate industry teamwork, preparing students for multidisciplinary environments.
Digital Tools & Software: Students engage with bioprocess modeling and regulatory compliance systems, learning how to translate laboratory data into business and regulatory insights.
Library & Research Resources: Access to UCC’s Boole Library and specialized scientific databases supports both laboratory and dissertation research.
Institute Links: The program is closely connected with Ireland’s biopharma ecosystem, ensuring students benefit from UCC’s partnerships with leading companies and research institutes.

Progression & Future Opportunities

Graduates of UCC’s MSc Biotechnology are exceptionally well prepared for careers in Ireland’s booming biopharmaceutical sector and beyond. With advanced training in cell and molecular biology, bioprocess engineering, and regulatory frameworks, alumni typically progress into roles such as Bioprocess Scientist, Quality Assurance Specialist, Regulatory Affairs Officer, and Research & Development Scientist. The program’s six‑month industry placement ensures graduates leave with both academic excellence and real-world experience:

Career Services: Students benefit from UCC’s Career Services and tailored support from the College of Science, Engineering and Food Science, including employer networking events, CV workshops, and interview coaching.
Employment Outcomes: UCC reports that 90% of MSc Biotechnology graduates enter industry roles, while 10% progress to PhD study, highlighting strong employability.
Industry Partnerships: The program is closely linked with Ireland’s biopharma ecosystem, offering placements and collaborations with leading companies such as Pfizer, Janssen, Eli Lilly, MSD, and Novartis.
Accreditation Value: As a Level 9 NFQ Master’s qualification, the degree holds long‑term recognition both in Ireland and internationally, supporting career mobility across regulated biotech and pharmaceutical industries.
Graduate Outcomes: Alumni progress into diverse roles in manufacturing, process control, regulatory affairs, and advanced therapy development, demonstrating the program’s ability to open multiple career pathways.

Further Academic Progression:
After completing the MSc Biotechnology, students may continue into PhD research programs within UCC’s School of Biochemistry and Cell Biology or pursue doctoral studies in bioprocess engineering, advanced therapy medicinal products (ATMPs), or immunotherapy manufacturing. This pathway allows graduates to deepen their expertise and prepare for leadership roles in academia, research, or industry innovation.